公开(公告)号：US10196614B2

公开(公告)日：2019-02-05

申请号：US14426635

申请日：2013-09-16

Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

Inventor： Edward Clark ,  Jay Wesley Chaplin

IPC: A61K47/48 ,  C12N7/00 ,  A61K39/12 ,  A61K39/385 ,  C07K16/28 ,  A61K39/29 ,  A61K47/68 ,  A61K39/00

Abstract: The present limiting provides compositions of CD 180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.

公开(公告)号：US10563179B2

公开(公告)日：2020-02-18

申请号：US16245459

申请日：2019-01-11

Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

Inventor： Edward Clark ,  Jay Wesley Chaplin

IPC: C12N7/00 ,  A61K39/29 ,  C07K16/28 ,  A61K39/12 ,  A61K39/385 ,  A61K47/68 ,  A61K39/00

Abstract: The present invention provides compositions of CD180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.

公开(公告)号：US11549102B2

公开(公告)日：2023-01-10

申请号：US16731846

申请日：2019-12-31

Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

Inventor： Edward Clark ,  Jay Wesley Chaplin

IPC: C12N7/00 ,  A61K39/29 ,  A61K39/12 ,  A61K39/385 ,  C07K16/28 ,  A61K47/68 ,  A61K39/00

Abstract: The present invention provides compositions of CD180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.

公开(公告)号：US20150238630A1

公开(公告)日：2015-08-27

申请号：US14426635

申请日：2013-09-16

Applicant: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

Inventor： Edward Clark ,  Jay Wesley Chaplin

IPC: A61K47/48 ,  A61K39/12 ,  C12N7/00 ,  A61K39/29

CPC classification number: C12N7/00 ,  A61K39/12 ,  A61K39/29 ,  A61K39/385 ,  A61K47/6811 ,  A61K47/6849 ,  A61K2039/55511 ,  A61K2039/55561 ,  A61K2039/6056 ,  C07K16/2896 ,  C07K2319/40 ,  C07K2319/74 ,  C12N2770/24132 ,  C12N2770/24134 ,  C12N2770/28033 ,  Y02A50/386 ,  Y02A50/394

Abstract: The present limiting provides compositions of CD 180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.

Abstract translation: 本限制提供了与异源抗原偶联的CD 180靶向分子的组合物及其在治疗和/或限制疾病中的用途。